204 related articles for article (PubMed ID: 22699449)
1. Association between BDNF polymorphism (Val66Met) and executive function in patients with amnestic mild cognitive impairment or mild Alzheimer disease.
Nagata T; Shinagawa S; Nukariya K; Yamada H; Nakayama K
Dement Geriatr Cogn Disord; 2012; 33(4):266-72. PubMed ID: 22699449
[TBL] [Abstract][Full Text] [Related]
2. Association between brain-derived neurotrophic factor (BDNF) gene polymorphisms and executive function in Japanese patients with Alzheimer's disease.
Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kawamura S; Agawa-Ohta M; Kasahara H; Nakayama K; Yamada H
Psychogeriatrics; 2011 Sep; 11(3):141-9. PubMed ID: 21951954
[TBL] [Abstract][Full Text] [Related]
3. The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study.
Bessi V; Mazzeo S; Bagnoli S; Padiglioni S; Carraro M; Piaceri I; Bracco L; Sorbi S; Nacmias B
Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):471-482. PubMed ID: 31560105
[TBL] [Abstract][Full Text] [Related]
4. Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease.
Nagata T; Kobayashi N; Shinagawa S; Yamada H; Kondo K; Nakayama K
J Neural Transm (Vienna); 2014 Apr; 121(4):433-41. PubMed ID: 24253237
[TBL] [Abstract][Full Text] [Related]
5. Association between neurotrophin-3 polymorphisms and executive function in Japanese patients with amnestic mild cognitive impairment and mild Alzheimer disease.
Kobayashi N; Nagata T; Shinagawa S; Nakayama R; Kondo K; Nakayama K; Yamada H
Dement Geriatr Cogn Disord; 2012; 34(3-4):190-7. PubMed ID: 23075484
[TBL] [Abstract][Full Text] [Related]
6. Brain derived neurotrophic factor Val66Met polymorphism and psychotic symptoms in Alzheimer's disease.
Pivac N; Nikolac M; Nedic G; Mustapic M; Borovecki F; Hajnsek S; Presecki P; Pavlovic M; Mimica N; Muck Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):356-62. PubMed ID: 21044653
[TBL] [Abstract][Full Text] [Related]
7. [Cognitive function, serum BDNF levels and BDNF gene Val66Met polymorphism in amnestic mild cognitive impairment].
Yu H; Zhang ZJ; Shi YM; Bai F; Qian Y; Yuan YG; Deng LL
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):321-5. PubMed ID: 18460776
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between amnestic-mild cognitive impairment and early-stage Alzheimer's disease using the Frontal Assessment Battery test.
Yamao A; Nagata T; Shinagawa S; Nukariya K; Ochiai Y; Kasahara H; Nakayama K
Psychogeriatrics; 2011 Dec; 11(4):235-41. PubMed ID: 22151243
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
10. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical association of the brain-derived-neurotrophic-factor val66met genotype with response inhibition.
Beste C; Baune BT; Domschke K; Falkenstein M; Konrad C
Neuroscience; 2010 Mar; 166(1):178-84. PubMed ID: 20034542
[TBL] [Abstract][Full Text] [Related]
12. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
[TBL] [Abstract][Full Text] [Related]
13. The Influence of BDNF Val66Met Polymorphism on Cognition, Cerebrospinal Fluid, and Neuroimaging Markers in Non-Demented Elderly.
Xia H; Wang M; Li JQ; Tan CC; Cao XP; Tan L; Yu JT;
J Alzheimers Dis; 2019; 68(1):405-414. PubMed ID: 30775992
[TBL] [Abstract][Full Text] [Related]
14. Association between nerve growth factor gene polymorphism and executive dysfunction in Japanese patients with early-stage Alzheimer's disease and amnestic mild cognitive impairment.
Nagata T; Shinagawa S; Nukariya K; Nakayama R; Nakayama K; Yamada H
Dement Geriatr Cogn Disord; 2011; 32(6):379-86. PubMed ID: 22301435
[TBL] [Abstract][Full Text] [Related]
15. Association between executive dysfunction and hippocampal volume in Alzheimer's disease.
Nagata T; Shinagawa S; Ochiai Y; Aoki R; Kasahara H; Nukariya K; Nakayama K
Int Psychogeriatr; 2011 Jun; 23(5):764-71. PubMed ID: 21106135
[TBL] [Abstract][Full Text] [Related]
16. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
[TBL] [Abstract][Full Text] [Related]
17. Physical exercise improves peripheral BDNF levels and cognitive functions in mild cognitive impairment elderly with different bdnf Val66Met genotypes.
Nascimento CM; Pereira JR; Pires de Andrade L; Garuffi M; Ayan C; Kerr DS; Talib LL; Cominetti MR; Stella F
J Alzheimers Dis; 2015; 43(1):81-91. PubMed ID: 25062900
[TBL] [Abstract][Full Text] [Related]
18. Brain-derived neurotrophic factor Val66Met polymorphism is associated with mild cognitive impairment in elderly patients with type 2 diabetes: a case-controlled study.
Liu J; Yang W; Luo H; Ma Y; Zhao H; Dan X
Aging Clin Exp Res; 2021 Jun; 33(6):1659-1666. PubMed ID: 32892314
[TBL] [Abstract][Full Text] [Related]
19. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han.
Yu H; Zhang Z; Shi Y; Bai F; Xie C; Qian Y; Yuan Y; Deng L
J Clin Psychiatry; 2008 Jul; 69(7):1104-11. PubMed ID: 18505307
[TBL] [Abstract][Full Text] [Related]
20. Impaired cognitive flexibility during sleep deprivation among carriers of the Brain Derived Neurotrophic Factor (BDNF) Val66Met allele.
Grant LK; Cain SW; Chang AM; Saxena R; Czeisler CA; Anderson C
Behav Brain Res; 2018 Feb; 338():51-55. PubMed ID: 28947280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
